This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi-Aventis. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Micael Guillot: Innovator in Amorphous Solid Dispersions
Introduction
Micael Guillot is an accomplished inventor based in Phoenixville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on amorphous solid dispersions. His expertise and dedication to research have led to the development of valuable formulations that enhance drug delivery.
Latest Patents
Micael Guillot holds a patent for his work titled "Amorphous solid dispersions." This patent discloses formulations comprising 7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide. His innovative approach in this area has the potential to improve the efficacy of pharmaceutical compounds.
Career Highlights
Throughout his career, Micael has worked with prominent companies in the pharmaceutical industry, including Sanofi-Aventis and Sanofi-Aventis U.S. LLC. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug formulation.
Collaborations
Micael has collaborated with notable professionals in his field, including Irwin C. Jacobs and John D. Higgins. These partnerships have fostered an environment of innovation and have led to advancements in pharmaceutical technologies.
Conclusion
Micael Guillot is a distinguished inventor whose work in amorphous solid dispersions has made a significant impact in the pharmaceutical industry. His contributions continue to influence drug formulation and delivery, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile